Low-dose propofol-induced amnesia is not due to a failure of encoding: Left inferior prefrontal cortex is still active Journal Article


Authors: Veselis, R. A.; Pryor, K. O.; Reinsel, R. A.; Mehta, M.; Pan, H.; Johnson, R.
Article Title: Low-dose propofol-induced amnesia is not due to a failure of encoding: Left inferior prefrontal cortex is still active
Abstract: Background: Propofol may produce amnesia by affecting encoding. The hypothesis that propofol weakens encoding was tested by measuring regional cerebral blood flow during verbal encoding. Methods: Seventeen volunteer participants (12 men; aged 30.4 ± 6.5 yr) had regional cerebral blood flow measured using H2O positron emission tomography during complex and simple encoding tasks (deep vs. shallow level of processing) to identify a region of interest in the left inferior prefrontal cortex (LIPFC). The effect of either propofol (n = 6, 0.9 μg/ml target concentration), placebo with a divided attention task (n = 5), or thiopental at sedative doses (n = 6, 3 μg/ml) on regional cerebral blood flow activation in the LIPFC was tested. The divided attention task was expected to decrease activation in the LIPFC. Results: Propofol did not impair encoding performance or reaction times, but impaired recognition memory of deeply encoded words 4 h later (median recognition of 35% [interquartile range, 17-54%] of words presented during propofol vs. 65% [38-91%] before drug; P < 0.05). Statistical parametric mapping analysis identified a region of interest of 6.6 cm in the LIPFC (T = 7.44, P = 0.014). Regional cerebral blood flow response to deep encoding was present in this region of interest in each group before drug (T > 4.41, P < 0.04). During drug infusion, only the propofol group continued to have borderline significant activation in this region (T = 4.00, P = 0.063). Conclusions: If the amnesic effect of propofol were solely due to effects on encoding, activation in the LIPFC should be minimal. Because LIPFC activation was not totally eliminated by propofol, the amnesic action of propofol must be present in other brain regions and/or affect other memory processes. Copyright © 2008 The American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.
Keywords: controlled study; clinical trial; placebo; dose response; neuroimaging; positron emission tomography; low drug dose; controlled clinical trial; randomized controlled trial; propofol; drug effect; dose-response relationship, drug; vascularization; brain; chemically induced disorder; cerebrum; positron-emission tomography; verbal memory; memory; attention; psychomotor performance; recognition; amnesia; task performance; signal processing; brain blood flow; normal human; hypnotics and sedatives; electroencephalography; frontal cortex; thiopental; hypnotic sedative agent; reaction time; prefrontal cortex; oxygen 15
Journal Title: Anesthesiology
Volume: 109
Issue: 2
ISSN: 0003-3022
Publisher: Lippincott Williams & Wilkins  
Date Published: 2008-08-01
Start Page: 213
End Page: 224
Language: English
DOI: 10.1097/ALN.0b013e31817fd8ae
PUBMED: 18648230
PROVIDER: scopus
PMCID: PMC2599915
DOI/URL:
Notes: --- - "Cited By (since 1996): 9" - "Export Date: 17 November 2011" - "CODEN: ANESA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert A Veselis
    98 Veselis
  2. Ruth A Reinsel
    78 Reinsel
  3. Kane Pryor
    8 Pryor
  4. Meghana Mehta
    18 Mehta